Effect of Pioglitazone Administered to Patients With Adrenomyeloneuropathy

PHASE2CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

January 31, 2016

Primary Completion Date

March 31, 2019

Study Completion Date

July 31, 2019

Conditions

AdrenomyeloneuropathyX-linked Adrenoleukodystrophy

Interventions

DRUG

Pioglitazone

Trial Locations (2)

Donostia University Hospital, Donostia / San Sebastian

Bellvitge University Hospital, L'Hospitalet de Llobregat

All Listed Sponsors

collaborator

Instituto de Salud Carlos III

OTHER_GOV

collaborator

Fundacion Hesperia

OTHER

collaborator

ELA España Association

UNKNOWN

lead

Pujol, Aurora, M.D.

INDIV

NCT03864523 - Effect of Pioglitazone Administered to Patients With Adrenomyeloneuropathy | Biotech Hunter | Biotech Hunter